Close Menu

NEW YORK – Single-cell sequencing firm 10x Genomics this week won a partial, interim stay of a permanent injunction resulting from a Bio-Rad Laboratories patent infringement lawsuit. The order, issued by the US Court of Appeals for the Federal Circuit, will allow 10x to sell its linked reads and CNV kits to new customers while the court considers 10x's motion to stay the injunction during the appeals process. 10x has appealed the permanent injunction as well as the jury verdict finding infringement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.